Galderma Group AG (XSWX:GALD) Issuance of Debt: CHF1,141 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALD Galderma Group AG XSWX:GALD
14 GF Score
Price CHF172.50
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Issuance of Debt?

Galderma Group AG XSWX:GALD +1.53% 14 Issuance of Debt is CHF1,141 Mil as of Dec. 2025. GuruFocus rates XSWX:GALD with a GF Score™ of 14/100. The stock has 4 warning signs investors should review.

Galderma Group AG's Issuance of Debt for the six months ended in Dec. 2025 was CHF194 Mil.

Galderma Group AG's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was CHF1,141 Mil.

Galderma Group AG Issuance of Debt Related Terms

Galderma Group AG Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Issuance of Debt Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
364.72 372.64 740.27 3,210.65 1,122.04

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial 137.50 2,652.80 564.38 947.38 193.65
XSWX:GALD
14GF Score
Galderma Group AG XSWX:GALD
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1,141 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of CHF1,141 Mil mean?
Galderma Group AG (XSWX:GALD) has a Issuance of Debt of CHF1,141 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Issuance of Debt too high?
Galderma Group AG's current Issuance of Debt is CHF1,141 Mil. Overall, Galderma Group AG has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Issuance of Debt compare to ZTS and UTHR?
Galderma Group AG's Issuance of Debt of CHF1,141 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Issuance of Debt is CHF1,141 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Issuance of Debt of CHF1,141 Mil. The current Issuance of Debt is CHF1,141 Mil. Galderma Group AG's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Issuance of Debt is CHF1,141 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
14GF Score

Get the complete analysis for XSWX:GALD

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF172.50
Price